RATIONALE: Inflammation is associated with symptoms in many chronic illnesses; however, this link has not been established in pulmonary arterial hypertension. OBJECTIVES: The objective of this study was to investigate the association between inflammatory markers and quality of life-related symptoms in patients with pulmonary arterial hypertension. We hypothesized that higher circulating IL-6 and tumor necrosis factor-α levels would be associated with worse quality of life-related symptoms. METHODS: We performed a secondary analysis using baseline and 3-month assessments of 62 subjects in a clinical trial ofaspirin and simvastatin to determine the association between plasma IL-6 and tumor necrosis factor-α levels and the Medical Outcomes Study Short Form-36 subscales (pain, vitality, mental health). MEASUREMENTS AND MAIN RESULTS:The mean age was 49.7±13.4 years; 87% were female. Higher IL-6 levels were significantly associated with lower Medical Outcomes Study Short Form-36 subscale scores, indicating worse bodily pain, vitality, and mental health (all P<0.01). Higher tumor necrosis factor-α levels were significantly associated with increased bodily pain, but better mental health scores. CONCLUSIONS:IL-6 and tumor necrosis factor-α levels are associated with certain quality of life domains in patients with pulmonary arterial hypertension. Clinical trial registered with www.clinicaltrials.gov (NCT00384865).
RCT Entities:
RATIONALE: Inflammation is associated with symptoms in many chronic illnesses; however, this link has not been established in pulmonary arterial hypertension. OBJECTIVES: The objective of this study was to investigate the association between inflammatory markers and quality of life-related symptoms in patients with pulmonary arterial hypertension. We hypothesized that higher circulating IL-6 and tumor necrosis factor-α levels would be associated with worse quality of life-related symptoms. METHODS: We performed a secondary analysis using baseline and 3-month assessments of 62 subjects in a clinical trial of aspirin and simvastatin to determine the association between plasma IL-6 and tumor necrosis factor-α levels and the Medical Outcomes Study Short Form-36 subscales (pain, vitality, mental health). MEASUREMENTS AND MAIN RESULTS: The mean age was 49.7±13.4 years; 87% were female. Higher IL-6 levels were significantly associated with lower Medical Outcomes Study Short Form-36 subscale scores, indicating worse bodily pain, vitality, and mental health (all P<0.01). Higher tumor necrosis factor-α levels were significantly associated with increased bodily pain, but better mental health scores. CONCLUSIONS:IL-6 and tumor necrosis factor-α levels are associated with certain quality of life domains in patients with pulmonary arterial hypertension. Clinical trial registered with www.clinicaltrials.gov (NCT00384865).
Authors: Emma Robertson Blackmore; Jan A Moynihan; David R Rubinow; Eva K Pressman; Michelle Gilchrist; Thomas G O'Connor Journal: Psychosom Med Date: 2011-09-23 Impact factor: 4.312
Authors: Sang Mi Kwak; Youn Seon Choi; Ho Min Yoon; Dae Gyun Kim; Seung Hun Song; Young Jae Lee; Chang Hwan Yeom; Su Jin Koh; Jeanno Park; Myung Ah Lee; Sang-Yeon Suh Journal: Palliat Med Date: 2011-08-01 Impact factor: 4.762
Authors: Aoife O'Donovan; Brian M Hughes; George M Slavich; Lydia Lynch; Marie-Therese Cronin; Cliona O'Farrelly; Kevin M Malone Journal: Brain Behav Immun Date: 2010-03-18 Impact factor: 7.217
Authors: Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau Journal: Eur Heart J Date: 2009-08-27 Impact factor: 29.983
Authors: Ellen L Poleshuck; Nancy L Talbot; Jan A Moynihan; Benjamin P Chapman; Kathi L Heffner Journal: Pain Med Date: 2013-04-22 Impact factor: 3.750
Authors: Corline Brouwers; Paula M C Mommersteeg; Ivan Nyklíček; Aline J Pelle; Bert L W J J M Westerhuis; Balázs M Szabó; Johan Denollet Journal: Biol Psychol Date: 2012-10-23 Impact factor: 3.251
Authors: Marie Rodling Wahlström; Magnus Olivecrona; Clas Ahlm; Anders Bengtsson; Lars-Owe D Koskinen; Silvana Naredi; Magnus Hultin Journal: Springerplus Date: 2014-02-18
Authors: Lea Ann Matura; Jamison Fargo; Jason S Fritz; Kerri A Smith; Anjali Vaidya; Diane Pinder; Christine Archer-Chicko; Harold I Palevsky; Allan I Pack; Marilyn S Sommers; Steven M Kawut Journal: Heart Lung Date: 2016-11-22 Impact factor: 2.210
Authors: Kurt W Prins; Stephen L Archer; Marc Pritzker; Lauren Rose; E Kenneth Weir; Alok Sharma; Thenappan Thenappan Journal: J Heart Lung Transplant Date: 2017-09-01 Impact factor: 10.247
Authors: Kurt W Prins; Thenappan Thenappan; E Kenneth Weir; Rajat Kalra; Marc Pritzker; Stephen L Archer Journal: J Am Heart Assoc Date: 2019-01-08 Impact factor: 5.501
Authors: Thomas P Walsh; Grayson L Baird; Michael K Atalay; Saurabh Agarwal; Daniel Arcuri; James R Klinger; Christopher J Mullin; Heather Morreo; Brynn Normandin; Sruti Shiva; Mary Whittenhall; Corey E Ventetuolo Journal: Pulm Circ Date: 2021-05-21 Impact factor: 3.017